@Lopez
not the first one this week either.
valuation gap is just too huge for some to ignore.
We love the fact MSB has reached $2.4B without developing 1 product by themselves to P3.
(now CYP may be only 2-4 years behind)
Better cells (straight to P2 and now P3 = CONSISTENT)
Less Invasive (no BM collection/ less injections for better results GvHD already)
Unlimited supply (unlike Temcell in Japan)
Global leader in IPSC derived MSCs (fact)
Other Peoples Money (multiple trials with OPM)
therefore cheaper products will follow.....
only time Lopez, and you should know this very very well by now.....17 years to US P3....still waiting.
@Lopeznot the first one this week either.valuation gap is just...
-
- There are more pages in this discussion • 366 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $34.32M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $58.84K | 310.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 33236 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 163350 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |